Myeloma Paper of the Day, July 5th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Study of Finnish myeloma patients finds improving overall survival from 2000 to 2021 (especially among transplanted patients), but also a rising incidence and increased healthcare resource utilization vs. matched controls.”
Source: Robert Orlowski/X
Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021
Authors: Kai Kysenius, Anna Anttalainen, Iiro Toppila, Tatu Miettinen, Mariann Lassenius, Juha Lievonen, Anu Partanen, Raija Silvennoinen and Mervi Putkonen.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
